Back
Agenus, Inc. 10K Form
Sell
32
AGEN
Agenus, Inc.
Last Price:
$4.08
Seasonality Move:
-7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | AGEN/Agenus, Inc. Quarterly |
| 2023-11-09 | 10Q | AGEN/Agenus, Inc. Quarterly |
| 2023-08-08 | 10Q | AGEN/Agenus, Inc. Quarterly |
| 2023-05-09 | 10Q | AGEN/Agenus, Inc. Quarterly |
| 2022-11-08 | 10Q | AGEN/Agenus, Inc. Quarterly |
| 2022-08-09 | 10Q | AGEN/Agenus, Inc. Quarterly |
Receive AGEN News And Ratings
See the #1 stock for the next 7 days that we like better than AGEN
AGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $103.5M |
|---|---|
| Cash Flow: | $-14.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-8.35 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.12750 |
|---|---|
| Net Income (TTM): | $-39.3M |
| Gross Margin: | $89.6M |
| Return on Equity: | 0% |
| Return on Assets: | -18.12% |
Agenus, Inc. Earnings Forecast
Key Agenus, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for AGEN is 86.63%.
-
The Selling, General & Administrative Expenses for AGEN have been equal to 69.47% of Gross Profit Margin.
-
The Research & Development expenses have been 150.32% of Revenue.
-
The Net Earning history of AGEN is -224.50% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Agenus, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AGEN |
| CUSIP: | 00847G |
| Website: | agenusbio.com |
Debt
| Debt-to-Equity Ratio: | -1.24 |
|---|---|
| Current Ratio: | 0.47 |
| Quick Ratio: | 0.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.24 |
AGEN Technical Analysis vs Fundamental Analysis
Sell
32
Agenus, Inc. (AGEN)
is a Sell
Is Agenus, Inc. a Buy or a Sell?
-
Agenus, Inc. stock is rated a SellThe current Agenus, Inc. [AGEN] share price is $4.06. The Score for AGEN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.